Posts by cstephenson@legacymedsearch.com
Pediatricians Give Thumbs-Down to FluMist Flu Vaccine
Pediatricians gave a final thumbs-down Tuesday to the only needle-free flu vaccine on the market, saying they do not recommend the FluMist vaccine for kids this year. It’s a symbolic rejection: Vaccine advisers to the Centers for Disease Control and Prevention have already recommended against FluMist nasal spray vaccine for this season, saying it has…
Read MoreMedtech Salaries on the Rise and Demand for High Quality Employees is Greater Than Ever
What can Medtech employees do the ensure they continue to grow in this strong but evolving marketplace? An informative article from Marie Thibault and MDDI. According to Paula Rutledge, President of Legacy MedSearch, 2016 has been the strongest year yet for Orlando-based Medtech recruiting company. Recently Paula was asked to provide insights on current…
Read MoreWorld’s First Drug-Free Miniature Wireless Pain Relief Neurostimulator
MIAMI–(BUSINESS WIRE)–Stimwave LLC, a medical device manufacturer and independent research institute headquartered in South Florida, has achieved long-term success for hundreds of pain patients during the early adaptor rollout of the world’s first miniature wireless pain relief system. Embraced by pain specialists seeking non-opioid treatments, the drug-free, breakthrough remedy offers new hope to the more…
Read MoreMedtronic, HeartWare complete $1.1 billion deal
Medtronic completed its acquisition of HeartWare International on Aug. 22, a deal intended to expand the company’s heart failure business. Medtronic agreed to pay $58.00 in cash for each outstanding share of HeartWare’s common stock. The deal is valued at approximately $1.1 billion. On June 27, Medtronic announced it had agreed to acquire HeartWare, which…
Read MoreZillion® Secures $28 Mill in Series C Financing to Enhance Digital Engagement Platform
NORWALK, Conn. and BOSTON, Aug. 30, 2016 /PRNewswire/ — Zillion Group, a leading technology solution for digital engagement, today announced the company has raised $28 million in its Series C round of fundraising. The round was led by TwinFocus Capital Partners, the premier boutique multifamily office for global ultra-high net worth families, entrepreneurs and professional investors.…
Read MoreFunctional Human Tissue-Engineered Liver Generated from Stem and Progenitor Cells
A research team led by investigators at The Saban Research Institute of Children’s Hospital Los Angeles has generated functional human and mouse tissue-engineered liver from adult stem and progenitor cells. Tissue-engineered Liver (TELi) was found to contain normal structural components such as hepatocytes, bile ducts and blood vessels. The study has been published online in…
Read MoreMedtronic, Zimmer Biomet Enter 2-level Cervical Disc and Robotic Markets
Since mid-May, both Medtronic and Zimmer Biomet have announced strategic moves in the 2-level cervical disc replacement and robotic surgery markets. In efforts to invigorate revenue growth, the two have focused on niche technologies that expand their portfolios—but have yet to prove wide scale adoption. Disc Replacement Zimmer Biomet’s $1 billion acquisition of LDR and…
Read MoreCold Plasma Can Be “Tuned” to Either Promote or Inhibit Bone Healing
Tuning cold plasma can either promote or inhibit bone formation. (pictured: Microsecond cold plasma filament pattern at different frequencies.) (PHILADELPHIA) – Cold plasma looks like the glow from the “Star Wars” blue light saber but this beam of energy, made of electrons that change polarity at micro-second or nanosecond speeds, could help bones heal faster, according…
Read MoreMR-Guided Brain Ultrasound Helps Rouse Coma Patient Back to Consciousness
Neuroscience researchers and clinicians at UCLA have used MR-guided ultrasound to help rouse a recovering coma patient to a more alert state of consciousness. They’re not certain about the extent to which the novel therapy contributed to the good outcome, but they’re sufficiently hopeful to have begun recruiting participants for a larger trial. Martin Monti,…
Read MoreAlere Sues Abbott to Compel Completion of $5.8 Billion Deal
Alere Inc. sued Abbott Laboratories to compel the completion of their pending $5.8 billion takeover deal, claiming the medical-device maker failed to get U.S. antitrust clearance in an effort to scuttle the contentious transaction. Abbott “has breached the merger agreement between the parties by failing to promptly secure antitrust approvals and other regulatory requirements,” Alere…
Read More